dc.contributorUniv Auckland
dc.contributorUniversidade Estadual Paulista (Unesp)
dc.date.accessioned2014-05-20T15:32:03Z
dc.date.accessioned2022-10-05T17:08:08Z
dc.date.available2014-05-20T15:32:03Z
dc.date.available2022-10-05T17:08:08Z
dc.date.created2014-05-20T15:32:03Z
dc.date.issued2009-06-01
dc.identifierChromatographia. Wiesbaden: Vieweg, v. 69, p. 237-240, 2009.
dc.identifier0009-5893
dc.identifierhttp://hdl.handle.net/11449/41051
dc.identifier10.1365/s10337-009-1053-8
dc.identifierWOS:000267330400021
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/3911987
dc.description.abstractFleroxacin is a third generation fluoroquinolone with broad spectrum antibacterial activity. In this work an LC-DAD method for the analysis of fleroxacin was developed and validated using UV detection at 286 nm. The method was validated for linearity, precision, robustness, LOD, LOQ, specificity and accuracy at concentrations of 0.2-20.0 mu g mL(-1) and r (2) = 1. The LOD and LOQ were 0.059 and 0.197 mu g, respectively, the recoveries were 99.92-102.0% and the CV was less than 2.0%. The LC-DAD validated method provided analytical sensitivity, specificity and reproducibility suitable for quality control analysis.
dc.languageeng
dc.publisherVieweg
dc.relationChromatographia
dc.relation1.401
dc.relation0,514
dc.rightsAcesso restrito
dc.sourceWeb of Science
dc.subjectColumn liquid chromatography
dc.subjectLiquid chromatography-diode array detection
dc.subjectQuality control
dc.subjectFleroxacin
dc.titleLC-DAD Determination of Fleroxacin in Bulk and Pharmaceutical Dosage Forms
dc.typeArtigo


Este ítem pertenece a la siguiente institución